Skip to main content

Advertisement

SpringerLink
Log in

Integrating imaging findings in evaluating the post-chemotherapy brain

  • SI: Neuroimaging Studies of Cancer and Cancer Treatment
  • Published:
Brain Imaging and Behavior Aims and scope Submit manuscript

Abstract

Cognitive complaints following cancer and cancer therapy are common. Many studies have investigated the effects of chemotherapy on the brain. However, the mechanisms for the associated cognitive impairment are not well understood. Some studies have also included brain imaging to investigate potential neurological substrates of cognitive changes. This review examines recent neuroimaging studies on cancer- and chemotherapy-related cognitive dysfunction in non-central nervous system cancers and compares findings across imaging modalities. Grey matter volume reductions and decreases in white matter integrity are seen after exposure to adjuvant chemotherapy for breast cancer, and functional studies have illuminated both hypo- and hyperactivations in many of the same regions months to years following therapy. These comparisons can assist in further characterizing the dysfunction reported by patients and contribute to a better understanding of the mechanisms involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Abraham, J., Haut, M. W., Moran, M. T., Filburn, S., Lemiuex, S., & Kuwabara, H. (2008). Adjuvant chemotherapy for breast cancer: effects on cerebral white matter seen in diffusion tensor imaging. Clinical Breast Cancer, 8(1), 88–91. doi:10.3816/CBC.2008.n.007.

    Article  PubMed  Google Scholar 

  • Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. [Research Support, N.I.H., Extramural Review]. Nature Reviews. Cancer, 7(3), 192–201. doi:10.1038/nrc2073.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., et al. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. [Comparative Study Research Support, U.S. Gov’t, P.H.S.]. Journal of Clinical Oncology, 20(2), 485–493.

    Article  CAS  PubMed  Google Scholar 

  • Baudino, B., D’Agata, F., Caroppo, P., Castellano, G., Cauda, S., Manfredi, M., et al. (2012). The chemotherapy long-term effect on cognitive functions and brain metabolism in lymphoma patients. The Quarterly Journal of Nuclear Medicine and Molecular Imaging, 56(6), 559–568.

    CAS  PubMed  Google Scholar 

  • Bergouignan, L., Lefranc, J. P., Chupin, M., Morel, N., Spano, J. P., & Fossati, P. (2011). Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. [Research Support, Non-U.S. Gov’t]. PLoS One, 6(10), e25349. doi:10.1371/journal.pone.0025349.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Burstein, H. J. (2007). Cognitive side-effects of adjuvant treatments. [Review]. Breast, 16(Suppl 2), S166–S168. doi:10.1016/j.breast.2007.07.027.

    Article  PubMed  Google Scholar 

  • Cabeza, R., & Nyberg, L. (2000). Imaging cognition II: an empirical review of 275 PET and fMRI studies. [Review]. Journal of Cognitive Neuroscience, 12(1), 1–47.

    Article  CAS  PubMed  Google Scholar 

  • Chiaravalloti, A., Pagani, M., Di Pietro, B., Danieli, R., Tavolozza, M., Travascio, L., et al. (2013). Is cerebral glucose metabolism affected by chemotherapy in patients with Hodgkin’s lymphoma? Nuclear Medicine Communications, 34(1), 57–63. doi:10.1097/MNM.0b013e32835aa7de.

    Article  CAS  PubMed  Google Scholar 

  • Cimprich, B., Reuter-Lorenz, P., Nelson, J., Clark, P. M., Therrien, B., Normolle, D., et al. (2010). Prechemotherapy alterations in brain function in women with breast cancer. [Research Support, Non-U.S. Gov’t]. Journal of Clinical and Experimental Neuropsychology, 32(3), 324–331. doi:10.1080/13803390903032537.

    Article  PubMed  Google Scholar 

  • de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., et al. (2012). Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: converging results from multimodal magnetic resonance imaging. [Research Support, Non-U.S. Gov’t]. Human Brain Mapping, 33(12), 2971–2983. doi:10.1002/hbm.21422.

    Article  PubMed  Google Scholar 

  • de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., van Dam, F. S., Nederveen, A. J., et al. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32(8), 1206–1219. doi:10.1002/hbm.21102.

    Article  PubMed  Google Scholar 

  • Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., et al. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. [Research Support, Non-U.S. Gov’t]. Journal of Clinical Oncology, 30(3), 274–281. doi:10.1200/JCO.2011.36.8571.

    Article  PubMed  Google Scholar 

  • Deprez, S., Amant, F., Yigit, R., Porke, K., Verhoeven, J., Van den Stock, J., et al. (2011). Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. [Research Support, Non-U.S. Gov’t]. Human Brain Mapping, 32(3), 480–493. doi:10.1002/hbm.21033.

    Article  PubMed  Google Scholar 

  • Dietrich, J., Monje, M., Wefel, J., & Meyers, C. (2008). Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. [Research Support, Non-U.S. Gov’t Review]. The Oncologist, 13(12), 1285–1295. doi:10.1634/theoncologist.2008-0130.

    Article  PubMed  Google Scholar 

  • Dijkstra, J. B., Houx, P. J., & Jolles, J. (1999). Cognition after major surgery in the elderly: test performance and complaints. [Research Support, Non-U.S. Gov’t]. British Journal of Anaesthesia, 82(6), 867–874.

    Article  CAS  PubMed  Google Scholar 

  • Dodds, C., & Allison, J. (1998). Postoperative cognitive deficit in the elderly surgical patient. [Review]. British Journal of Anaesthesia, 81(3), 449–462.

    Article  CAS  PubMed  Google Scholar 

  • Eheman, C., Henley, S. J., Ballard-Barbash, R., Jacobs, E. J., Schymura, M. J., Noone, A. M., et al. (2012). Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. [Editorial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Cancer, 118(9), 2338–2366. doi:10.1002/cncr.27514.

    Article  PubMed  Google Scholar 

  • Ferguson, R. J., & Ahles, T. A. (2003). Low neuropsychologic performance among adult cancer survivors treated with chemotherapy. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. Current Neurology and Neuroscience Reports, 3(3), 215–222.

    Article  PubMed  Google Scholar 

  • Ferguson, R. J., McDonald, B. C., Saykin, A. J., & Ahles, T. A. (2007). Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. [Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Twin Study]. Journal of Clinical Oncology, 25(25), 3866–3870. doi:10.1200/JCO.2007.10.8639.

    Article  PubMed Central  PubMed  Google Scholar 

  • Inagaki, M., Yoshikawa, E., Matsuoka, Y., Sugawara, Y., Nakano, T., Akechi, T., et al. (2007). Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. [Comparative Study Research Support, Non-U.S. Gov’t]. Cancer, 109(1), 146–156. doi:10.1002/cncr.22368.

    Article  PubMed  Google Scholar 

  • Kesler, S., Janelsins, M., Koovakkattu, D., Palesh, O., Mustian, K., Morrow, G., et al. (2012). Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain, Behavior, and Immunity. doi:10.1016/j.bbi.2012.05.017.

    PubMed Central  PubMed  Google Scholar 

  • Kesler, S. R., Bennett, F. C., Mahaffey, M. L., & Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic breast cancer. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Clinical Cancer Research, 15(21), 6665–6673. doi:10.1158/1078-0432.CCR-09-1227.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kesler, S. R., Kent, J. S., & O’Hara, R. (2011). Prefrontal cortex and executive function impairments in primary breast cancer. [Comparative Study Research Support, N.I.H., Extramural]. Archives of Neurology, 68(11), 1447–1453. doi:10.1001/archneurol.2011.245.

    Article  PubMed Central  PubMed  Google Scholar 

  • Koppelmans, V., Breteler, M. M., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. B. (2012a). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30(10), 1080–1086. doi:10.1200/JCO.2011.37.0189.

    Article  PubMed  Google Scholar 

  • Koppelmans, V., de Ruiter, M. B., van der Lijn, F., Boogerd, W., Seynaeve, C., van der Lugt, A., et al. (2012b). Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy. [Research Support, Non-U.S. Gov’t]. Breast Cancer Research and Treatment, 132(3), 1099–1106. doi:10.1007/s10549-011-1888-1.

    Article  CAS  PubMed  Google Scholar 

  • Koppelmans, V., Groot, M. D., de Ruiter, M. B., Boogerd, W., Seynaeve, C., Vernooij, M. W., et al. (2012c). Global and focal white matter integrity in breast cancer survivors 20 years after adjuvant chemotherapy. Human Brain Mapping. doi:10.1002/hbm.22221.

    PubMed  Google Scholar 

  • Kreukels, B. P., Hamburger, H. L., de Ruiter, M. B., van Dam, F. S., Ridderinkhof, K. R., Boogerd, W., et al. (2008). ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. [Clinical Trial Research Support, Non-U.S. Gov’t]. Clinical Neurophysiology, 119(3), 533–541. doi:10.1016/j.clinph.2007.11.011.

    Article  PubMed  Google Scholar 

  • Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., Muller, M. J., et al. (2006). Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study. [Comparative Study Research Support, Non-U.S. Gov’t]. Clinical Breast Cancer, 7(1), 67–78. doi:10.3816/CBC.2006.n.015.

    Article  CAS  PubMed  Google Scholar 

  • Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., & van Dam, F. S. (2005). Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. [Research Support, Non-U.S. Gov’t]. Breast Cancer Research and Treatment, 94(1), 53–61. doi:10.1007/s10549-005-7093-3.

    Article  CAS  PubMed  Google Scholar 

  • McAllister, T. W., Saykin, A. J., Flashman, L. A., Sparling, M. B., Johnson, S. C., Guerin, S. J., et al. (1999). Brain activation during working memory 1 month after mild traumatic brain injury: a functional MRI study. [Clinical Trial Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Neurology, 53(6), 1300–1308.

    Article  CAS  PubMed  Google Scholar 

  • McAllister, T. W., Sparling, M. B., Flashman, L. A., Guerin, S. J., Mamourian, A. C., & Saykin, A. J. (2001). Differential working memory load effects after mild traumatic brain injury. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. NeuroImage, 14(5), 1004–1012. doi:10.1006/nimg.2001.0899.

    Article  CAS  PubMed  Google Scholar 

  • McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Breast Cancer Research and Treatment, 123(3), 819–828. doi:10.1007/s10549-010-1088-4.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • McDonald, B. C., Conroy, S. K., Ahles, T. A., West, J. D., & Saykin, A. J. (2012a). Alterations in brain activation during working memory processing associated with breast cancer and treatment: a prospective functional magnetic resonance imaging study. [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Journal of Clinical Oncology, 30(20), 2500–2508. doi:10.1200/JCO.2011.38.5674.

    Article  PubMed  Google Scholar 

  • McDonald, B. C., Conroy, S. K., Smith, D. J., West, J. D., & Saykin, A. J. (2012b). Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study. Brain, Behavior, and Immunity. doi:10.1016/j.bbi.2012.05.007.

    PubMed  Google Scholar 

  • Menon, V., Boyett-Anderson, J. M., Schatzberg, A. F., & Reiss, A. L. (2002). Relating semantic and episodic memory systems. [Clinical Trial Research Support, U.S. Gov’t, P.H.S.]. Brain Research. Cognitive Brain Research, 13(2), 261–265.

    Article  PubMed  Google Scholar 

  • Minisini, A., Atalay, G., Bottomley, A., Puglisi, F., Piccart, M., & Biganzoli, L. (2004). What is the effect of systemic anticancer treatment on cognitive function? The Lancet Oncology, 5(5), 273–282. doi:10.1016/s1470-2045(04)01465-2.

    Article  PubMed  Google Scholar 

  • Monk, T. G., Weldon, B. C., Garvan, C. W., Dede, D. E., van der Aa, M. T., Heilman, K. M., et al. (2008). Predictors of cognitive dysfunction after major noncardiac surgery. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Anesthesiology, 108(1), 18–30. doi:10.1097/01.anes.0000296071.19434.1e.

    Article  PubMed  Google Scholar 

  • Nelson, W. L., & Suls, J. (2013). New approaches to understand cognitive changes associated with chemotherapy for non-central nervous system tumors. Journal of Pain and Symptom Management. doi:10.1016/j.jpainsymman.2012.11.005.

    Google Scholar 

  • Nguyen, A., Geist, C., Ganz, P. A., L., K., Castellon, S. A., Irwin, M., et al. (2012). Effects of adjuvant therapy on cerebral function during short-term and long-term memory tasks. The Journal of Nuclear Medicine, 53 (Supplemental 1)(Abstract No.1956).

  • Perry, A., & Schmidt, R. E. (2006). Cancer therapy-associated CNS neuropathology: an update and review of the literature. [Review]. Acta Neuropathologica, 111(3), 197–212. doi:10.1007/s00401-005-0023-y.

    Article  CAS  PubMed  Google Scholar 

  • Pomykala, K. L., & Silverman, D. H. S. (2012). Alterations in brain structure and function after chemotherapy for cancer. Future Neurology, 7(4), 443–452.

    Article  CAS  Google Scholar 

  • Price, C. C., Garvan, C. W., & Monk, T. G. (2008). Type and severity of cognitive decline in older adults after noncardiac surgery. [Comparative Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Anesthesiology, 108(1), 8–17. doi:10.1097/01.anes.0000296072.02527.18.

    Article  PubMed Central  PubMed  Google Scholar 

  • Roth, R. M., Isquith, P. K., & Gioia, G. A. (2005). BRIEF-A behavior rating inventory of executive function-adult version professional manual. Lutz: Psychological Assessment Resources.

    Google Scholar 

  • Saykin, A. J., Wishart, H. A., Rabin, L. A., Flashman, L. A., McHugh, T. L., Mamourian, A. C., et al. (2004). Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]. Brain, 127(Pt 7), 1574–1583. doi:10.1093/brain/awh177.

    Article  PubMed  Google Scholar 

  • Schagen, S. B., Hamburger, H. L., Muller, M. J., Boogerd, W., & van Dam, F. S. (2001). Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function. [Clinical Trial Comparative Study Multicenter Study Randomized Controlled Trial]. Journal of Neuro-Oncology, 51(2), 159–165.

    Article  CAS  PubMed  Google Scholar 

  • Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. (2011). Pre-chemotherapy differences in visuospatial working memory in breast cancer patients compared to controls: an FMRI study. Frontiers in Human Neuroscience, 5, 122. doi:10.3389/fnhum.2011.00122.

    Article  PubMed Central  PubMed  Google Scholar 

  • Scherling, C., Collins, B., Mackenzie, J., Bielajew, C., & Smith, A. (2012a). Prechemotherapy differences in response inhibition in breast cancer patients compared to controls: a functional magnetic resonance imaging study. [Research Support, Non-U.S. Gov’t]. Journal of Clinical and Experimental Neuropsychology, 34(5), 543–560. doi:10.1080/13803395.2012.666227.

    Article  Google Scholar 

  • Scherling, C., Collins, B., Mackenzie, J., Lepage, C., Bielajew, C., & Smith, A. (2012b). Structural brain differences in breast cancer patients compared to matched controls prior to chemotherapy. International Journal of Biology, 4(2), 3–25. doi:10.5539/ijb.v4n2p3.

    Google Scholar 

  • Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. [10.1038/nrc2507]. Nature Reviews. Cancer, 8(11), 887–899.

    Article  CAS  PubMed  Google Scholar 

  • Silverman, D. H., Dy, C. J., Castellon, S. A., Lai, J., Pio, B. S., Abraham, L., et al. (2007). Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy. [Research Support, Non-U.S. Gov’t]. Breast Cancer Research and Treatment, 103(3), 303–311. doi:10.1007/s10549-006-9380-z.

    Article  CAS  PubMed  Google Scholar 

  • Taillibert, S., Voillery, D., & Bernard-Marty, C. (2007). Chemobrain: is systemic chemotherapy neurotoxic? [Review]. Current Opinion in Oncology, 19(6), 623–627. doi:10.1097/CCO.0b013e3282f0e224.

    Article  PubMed  Google Scholar 

  • van Dam, F. S., Schagen, S. B., Muller, M. J., Boogerd, W., vd Wall, E., Droogleever Fortuyn, M. E., et al. (1998). Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. [Clinical Trial Randomized Controlled Trial]. Journal of the National Cancer Institute, 90(3), 210–218.

    Article  PubMed  Google Scholar 

  • Vardy, J., Booth, C., Pond, G. R., Zhan, H., Galica, J., Dhillon, H., et al. (2007). Cytokine levels in patients with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. Chicago: Abstract Presented at the American Society of Clinical Oncology- Poster, Patient and Survivor Care. 9070.

    Google Scholar 

  • Videnovic, A., Semenov, I., Chua-Adajar, R., Baddi, L., Blumenthal, D. T., Beck, A. C., et al. (2005). Capecitabine-induced multifocal leukoencephalopathy: a report of five cases. [Case Reports]. Neurology, 65(11), 1792–1794. doi:10.1212/01.wnl.0000187313.83515.7e. discussion 1685.

    Article  CAS  PubMed  Google Scholar 

  • Wager, T. D., & Smith, E. E. (2003). Neuroimaging studies of working memory: a meta-analysis. [Meta-Analysis Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S. Review]. Cognitive, Affective, & Behavioral Neuroscience, 3(4), 255–274.

    Article  Google Scholar 

  • Wefel, J. S., Kayl, A. E., & Meyers, C. A. (2004). Neuropsychological dysfunction associated with cancer and cancer therapies: a conceptual review of an emerging target. [Review]. British Journal of Cancer, 90(9), 1691–1696. doi:10.1038/sj.bjc.6601772.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Wefel, J. S., & Schagen, S. B. (2012). Chemotherapy-related cognitive dysfunction. Current Neurology and Neuroscience Reports, 12(3), 267–275. doi:10.1007/s11910-012-0264-9.

    Article  CAS  PubMed  Google Scholar 

  • Wishart, H. A., Saykin, A. J., McDonald, B. C., Mamourian, A. C., Flashman, L. A., Schuschu, K. R., et al. (2004). Brain activation patterns associated with working memory in relapsing-remitting MS. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]. Neurology, 62(2), 234–238.

    Article  CAS  PubMed  Google Scholar 

  • Yoshikawa, E., Matsuoka, Y., Inagaki, M., Nakano, T., Akechi, T., Kobayakawa, M., et al. (2005). No adverse effects of adjuvant chemotherapy on hippocampal volumein Japanese breast cancer survivors. Breast Cancer Research and Treatment, 92(1), 81–84. doi:10.1007/s10549-005-1412-6.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ahmanson Translational Imaging Division, Department of Molecular & Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA

    K. L. Pomykala & D. H. S. Silverman

  2. Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands

    M. B. de Ruiter

  3. Department of Radiology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium

    S. Deprez

  4. Center for Neuroimaging, Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA

    B. C. McDonald

  5. Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, 200 Medical Plaza, Suite B114 Mail Code: 737024, Los Angeles, CA, 90095-7370, USA

    D. H. S. Silverman

Authors
  1. K. L. Pomykala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. B. de Ruiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Deprez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. C. McDonald
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. H. S. Silverman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. H. S. Silverman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pomykala, K.L., de Ruiter, M.B., Deprez, S. et al. Integrating imaging findings in evaluating the post-chemotherapy brain. Brain Imaging and Behavior 7, 436–452 (2013). https://doi.org/10.1007/s11682-013-9239-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11682-013-9239-y

Keywords

Search

Navigation